A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel Group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 301)
Phase of Trial: Phase III
Latest Information Update: 17 Jan 2018
At a glance
- Drugs SHP 647 (Primary)
- Indications Ulcerative colitis
- Focus Registrational; Therapeutic Use
- Sponsors Shire
- 11 Dec 2017 Status changed from not yet recruiting to recruiting.
- 22 Aug 2017 Status changed from planning to not yet recruiting.
- 25 May 2017 New trial record